Product Details:
Strength | 25 mg |
Packaging Size | 8 x 5 x 2.5 ml |
Brand | Salbutamol Nebulizer |
Manufacturer | cipla |
Composition | Nebuliser Solution A clear, colourless to pale yellow solution in a clear, plastic single dose ampo |
Prescription/Non prescription | Prescription |
Also gives | Cipla, Third Party Manufacturing |
Form | Nebuliser Solution |
Deals in | Third Party Manufacturing, PCD Pharma |
Shelf life | 2 year |
Size | 8 x 5 x 2.5 ml |
Color | A clear, colorless |
Gender | Unisex |
Storage | Cool place |
Country of Origin | Made in India |
Treatment | Used as a diluent for diluting,Salbutamol Nebuliser Solution is indicated for use in the routine man |
Salbutamol Nebuliser Solution are indicated in adults, adolescents and children aged 4 years and above, see section 4.2.
Salbutamol Nebuliser Solution is indicated for use in the routine management of chronic bronchospasm unresponsive to conventional therapy and the treatment of acute severe asthma.
Posology and method of administrationSalbutamol Nebuliser Solution is for inhalation use only, to be breathed in through the mouth, under the direction of a physician, using a suitable nebuliser, via a face mask or T piece or via an endotracheal tube.
To open the plastic ampoule, take a strip of ampoules from the foil pack, remove one ampoule, replacing the rest back in the foil pack, and replace the foil pack back in the carton. Hold the ampoule upright and open it by twisting off the top. Squeeze the liquid into the solution holder of the machine.
Private purchase of nebuliser devices for use at home to deliver rescue therapy for the acute treatment of asthma in children and adolescents is not recommended.
Only specialists in respiratory medicine should initiate and clinically manage use of nebulisers and associated nebulised medicines at home for acute treatment of asthma in children and adolescents.
Children should be trained in the correct use of their device to deliver rescue therapy and use should be supervised by a responsible adult.
Urgent medical assistance should be sought if worsening asthma symptoms are not relieved by rescue medicines, even if there is short-term recovery following use of prescribed nebulised medication.
The solution should not be injected or swallowed.
Dosage:
Adults (including the elderly)
2.5 mg to 25 mg salbutamol up to four times a day. Up to 40 mg per day can be given under strict medical supervision in hospital.
Paediatric Population
Children aged 12 years and over: Dose as per adult population.
Children aged 4 to 11 years: 2.5mg to 5mg up to four times a day.
Additional Information: